Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910455895503321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910780602903321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.] |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
| Descrizione fisica | 1 online resource (2 volumes) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
RathboneMichael J. <1957->
HadgraftJonathan <1950-> RobertsMichael S. <1949-> LaneMajella E |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910780901203321 |
| New York : , : CRC Press, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.] |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | New York : , : CRC Press, , 2008 |
| Descrizione fisica | 1 online resource (2 volumes) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) |
RathboneMichael J. <1957->
HadgraftJonathan <1950-> RobertsMichael S. <1949-> LaneMajella E |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910800075903321 |
| New York : , : CRC Press, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.]
| Modified-release drug delivery technology / / edited by Michael J. Rathbone. [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : , : Informa Healthcare, , 2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910800076803321 |
| New York : , : Informa Healthcare, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology . Volume 2 / / edited by Michael J. Rathbone ... [et al.]
| Modified-release drug delivery technology . Volume 2 / / edited by Michael J. Rathbone ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, : Informa Healthcare, c2008 |
| Descrizione fisica | 1 online resource (2 volumes) : illustrations |
| Disciplina | 615/.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-09286-5
1-4200-4526-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology""
""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" ""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" ""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" ""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" |
| Record Nr. | UNINA-9910807468003321 |
| New York, : Informa Healthcare, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.]
| Modified-release drug delivery technology . Volume 1 / / edited by Michael J. Rathbone ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, : Informa Healthcare, c2008 |
| Descrizione fisica | 1 online resource (514 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | RathboneMichael J. <1957-> |
| Collana | Drugs and the pharmaceutical sciences |
| Soggetto topico |
Controlled release technology
Controlled release preparations Drug delivery systems Pharmaceutical technology |
| ISBN |
0-429-14580-2
1-4200-4436-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Preface; Contents; Chapter 1. Patent and Other Intellectual Property Rights in Drug Delivery; Chapter 2. Intellectual Property Developments and Issues in India; Chapter 3. Parameter Claims at the European Patent Office; Chapter 4. Japan's Patent Issues Relating to Modified Drug Delivery Technology; Chapter 5. Oral Transmucosal Drug Delivery; Chapter 6. Pilocarpine Buccal Insert; Chapter 7. OraVescent Drug Delivery System: A Novel Technology for the Transmucosal Delivery of Drugs; Chapter 8. DentiPatch Development; Chapter 9. Medicated Chewing Gum
Chapter 10. The Oral PowderJect Device for Mucosal Drug DeliveryChapter 11. The PerioChipTM: A Biodegradable Device for the Controlled Delivery of Chlorhexidine in the Subgingival Environment; Chapter 12. Modified-Release Delivery Systems for Oral Use; Chapter 13. Advances in Cellulose Ether-Based Modified-Release Technologies; Chapter SQZgelTM; Chapter 15. Thiolated Polymers for Controlled Release; Chapter 16. Two Concepts, One Technology: Controlled-Release Solid Dispersions Using Melt Extrusion (Meltrex) Chapter 17. Threeform-Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily AdministrationChapter 18. Floating Gastroretentive Capsule for Controlled Drug Delivery; Chapter 19. Thin Film Oral Dosage Forms; Chapter 21. Enhanced Gastroretentive Dosage Form with Minimal Food Effects: GIRESTM; Chapter 22. Advancing Gastrointestinal PermeationEnhancement Formulations intothe Clinic: GIPETTM; Chapter 23. The Micropump Technology; Chapter 24. A Novel Microparticle Technology for Tailored Drug Release in the Gastrointestinal Tract Chapter 25. Lipid Nanoparticles (SLN, NLC, LDC) for the Enhancement of Oral AbsorptionChapter 26. Colonic Drug Delivery; Chapter 27. Biopolymers and Colonic Delivery; Chapter 28. Enteric Coating for Colonic Delivery; Chapter 29. Programmed Drug Delivery Systems and the Colon; Chapter 30. PulsincapTM and Hydrophilic Sandwich Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies; Chapter 31. Targeting the Colon Using COLALTM: A Novel Bacteria-Sensitive Drug Delivery System; Chapter 32. Development of the Egalet Technology Chapter 33. Regulatory Aspects in Modified-Release Drug DeliveryChapter 34. Regulatory Issues in the United States Relating to Modified-Release Drug Formulations; Chapter 35. Japanese Regulatory Issues on Modified-Release Drug Products; Chapter 36. Regulatory Aspects of Delivery Systems in the European Union; Chapter 37. Canadian Regulatory Requirements for Drug Approval; Chapter 38. Regulating Modified-Release Drug Delivery Technologies in Australia; Back Cover |
| Record Nr. | UNINA-9910807006703321 |
| New York, : Informa Healthcare, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||